ABOUT US. Invivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. Our mission is also centered around developing products for use within vulnerable populations, such as the immunocompromised. By leveraging state-of-the-art viral surveillance, predictive modeling and advanced antibody engineering tec...
ABOUT US. Invivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facil...
ABOUT US. Invivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. Our mission is also centered around developing products for use within vulnerable populations, such as the immunocompromised. By leveraging state-of-the-art viral surveillance, predictive modeling and advanced antibody engineering tec...
ABOUT US. Invivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. Our mission is also centered around developing products for use within vulnerable populations, such as the immunocompromised. By leveraging state-of-the-art viral surveillance, predictive modeling and advanced antibody engineering tec...
ABOUT US. Invivyd is on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. Our mission is also centered around developing products for use within vulnerable populations, such as the immunocompromised. By leveraging state-of-the-art viral surveillance, predictive modeling and advanced antibody engineering tec...
